IMMUNOCLIN CORP (IMCL)

0.16
OTC Markets
Prev Close 0.16
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.10 / 0.19
Exchange OTC Markets
Shares Outstanding 28.83B
Market Cap 4.58M
Div & Yield N.A. (N.A)

Wednesday's Health Winners & Losers

Forest Labs is falling.

Icahn Named ImClone Chairman

Also, the interim CEO steps down.

Let's Be Brutally Honest

Let's Be Brutally Honest

Some readers take issue with a Dynavax column.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Osiris Therapeutics is stronger.

Sanofi Denies Pursuing ImClone

Sanofi Denies Pursuing ImClone

The company says it didn't make an acquisition offer for the biotech.

ImClone's Kies Resigns

Carl Icahn gets his way as the chairman leaves the board.

Thursday's Daily Blog Watch

Somebody doesn't like Sara Lee, the next Jobs, and what Estee Lauder can't cover up.

Dow Sets Another Record

For the second straight session, the industrials hit an all-time high. The Nasdaq rises more than 2%.

ImClone: Two Rights Make a Wrong

ImClone: Two Rights Make a Wrong

Both ImClone and Carl Icahn have valid points, but the battle's likely a lose-lose for all.

More Weirdness at ImClone

More Weirdness at ImClone

The company says Carl Icahn wouldn't support another firm's $36-a-share buyout offer.

Funny Money: A Little Caviar and Sympathy

Jailbound or not, Fastow, Ebbers, Alexander and Dunn deserve our understanding.

ImClone the Drama King

ImClone the Drama King

This biotech is haunted by competition and internal strife. Plus, more on the Dow's flirtation with history.

Dow Record Remains Elusive

The index again ends just short of setting an all-time high.

ImClone CFO Steps Down

Ana Stancic is named senior vice president of finance.

Wheels Coming Off at ImClone Systems

Until there's more stability, stay away from the stock.

Stocks Headed for More Gains

Futures are pointing to a higher open for blue chips and tech stocks.

Amgen Cancer Drug Approved

The FDA clears the colorectal cancer drug Vectibix.

Icahn Shops for More Federated Shares

Icahn Shops for More Federated Shares

The billionaire investor plans to buy up to $500 million of the department-store-operator's stock.

Funny Money: Shortsighted

Funny Money: Shortsighted

Hedge funds lead us down the primrose path. Plus, what do Halliburton and McDonald's have to do with bad spinach?

The Five Dumbest Things on Wall Street This Week

The Five Dumbest Things on Wall Street This Week

ImClone in-fighting; BP bungling; addled Amaranth; Ford flummoxed; Dell hard sell.

Biotechs' Pipeline Dreams

Biotechs' Pipeline Dreams

Drug development news could lift a raft of stocks into year-end.

ImClone's Indefinite Future

ImClone's Indefinite Future

Major changes are taking place at the biotech, including the addition of Carl Icahn to the board.

Stocks Hesitate Pre-Fed

Yahoo!'s warning and weaker housing starts inject anxiety. Plus, liquidity abounds.

Yahoo! Spooks Tech Sector

Wall Street pares its losses but ends lower. Internet shares sink.

Patent Setback Hits ImClone

Patent Setback Hits ImClone

Shares fall 6%.

Stocks Set for Lower Start

Stocks Set for Lower Start

Futures are weaker a day ahead of the Fed meeting on rates.

Weekend Reading: Countervailing Winds

Weekend Reading: Countervailing Winds

Sliding oil prices could give the market a lift, if bad housing news doesn't grab the spotlight.

Funny Money: The Next New Business Model

Funny Money: The Next New Business Model

Paris Hilton, Sony, Fox and the federal courts provide a terrifying vision of the not-so-distant future.

Icahn May Join ImClone Board

Also, three of his recommended candidates will be on the list of director nominees.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

Cephalon rises, but Genitope is lower.